Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization

Cancer Research

Volumn 57, Issue 14, 1997, Pages 2860-2864

  Richter, Jan ^a   Jiang, Feng ^a   Görög, Jean Philippe ^a   Sartorius, Gideon ^a   Egenter, Carole ^a   Gasser, Thomas C ^a   Moch, Holger ^a   Mihatsch, Michael J ^a   Sauter, Guido ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GENOME; HUMAN; HUMAN TISSUE; HYBRIDIZATION; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; FEMALE; HUMANS; MALE; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; ONCOGENES; URINARY BLADDER NEOPLASMS;

EID: 0030875221     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Raghavan, D., Shipley, W., Garnick, M., Russel, P., and Richie, J. Biology and management of bladder cancer. N. Engl. J. Med. 322: 1129-1138, 1990.
2. Knowles, M. A., Elder, P. A., Williamson, M., Cairns, J. P., Shaw, M. E., and Law, M. G. Allelotype of human bladder cancer. Cancer Res., 54: 531-538, 1994.
3. Kallioniemi, A., Kallioniemi, O., Citro, G., Sauter, G., DeVries, S., Kerschmann, R., Carroll, P., and Waldman, F. Identification of novel DNA amplifications and deletions in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes & Cancer, 12: 213-219, 1995.
4. Voorter, C., Joos, S., Bringuier, P. P., Vallinga, M., Poddighe, P., Schalken, J., du Manoir, S., Ramaekers, F., Lichter, P., Hopman, A. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am. J. Pathol., 146: 1341-1354, 1995.
5. Kallioniemi, A., Kallioniemi, O., Sudar, D., Rutovitz, D., Gray, J., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
6. Spruck, C. H., III, Ohneseit, P. F., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmütte, C., Yang, A S., Cote, R., Dubeau, L., Nichols, P. W., Hermann, G. G., Steven, K., Horn, T., Skinner, D. G., and Jones, P. A. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784-788, 1994.
7. Moch, H., Presti, J. C., Sauter, G., Buchholz, N., Jordan, P., Mihatsch, M. J., and Waldman, F. M. Comparative genomic hybridization for detection of DNA copy number abnormalities in renal cell carcinoma. Cancer Res., 56: 27-30, 1996.
8. Cairns, P., Shaw, M. E., and Knowles, M. A. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene, 8: 1083-1085, 1993.
9. Sauter, G., Moch, H., Carroll, P., Kurschmann, R., Mihatsch, M., and Waldman, F. Chromosome 9 loss detected by fluorescence in situ hybridization. Int. J. Cancer, 64: 99-103, 1995.
10. Mitelman, F. Catalog of Chromosome Aberrations in Cancer. New York: Wiley-Liss, 1994.
11. Simoneau, A. R., Spruck, C. H., III, Gonzalez-Zulueta, M. Gonzalgo, M. L., Chan, M. F., Tsai, Y. C., Dean, M., Steven, K., Horn, T., and Jones, P. A. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res., 56: 5039-5043, 1996.
12. Poddighe, P. J., Ramaekers, F. C. S., Smeets, A. W. G. B., Vooijs, G. P., and Hopman, A. H. N. Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe. Cancer Res., 52: 4929-4934, 1992.
13. Sauter, G., Moch, H., Wagner, U., Novotna, H., Gasser, T., Mattarelli, G., Mihatsch, M., and Waldman, F. Y Chromosome loss detected by FISH in bladder cancer. Cancer Genet. Cytogenet., 82: 163-169, 1995.
14. Heselmeyer, K., Schrock, E., du Manoir, S., Blegen, H., Shah, K., Steinbeck, R., Auer, G., and Ried, T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. USA, 93: 479-484, 1996.
15. Furihata, M., Inoue, K., Ohtsuki, Y., Hashimoto, H., Terao, N., and Fujita, Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res., 53: 4823-4827, 1993.
16. Barbacid, M. Nerve growth factor. Oncogene, 8: 2033-2042, 1993.
17. Sutrave, P., and Hughes, S. The SKI oncogene, Oncogene, 6: 353-356, 1991.
18. Coombs, L. M., Pigott, D. A., Sweeney, E., Proctor, A. J., Eydmann, M. E., Parkinson, C., and Knowles, M. A. Amplification and overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Br. J. Cancer, 63: 601-608, 1991.
19. Sauter, G., Moch, H., Moore, D., Carroll, P., Kerschmann, R., Chew, K., Mihatsch, M. J., Gudat, F., and Waldman, F. Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res., 53: 2199-2203, 1993.
20. Proctor, A. J., Coombs, L. M., Cairns, J. P., and Knowles, M. A. Amplification at chromosome 1 1q13 in transitional cell tumours of the bladder. Oncogene, 6: 789-795, 1991.
21. Lianes, P., Orlow, I., Zhang, Z. F., Oliva, M. R., Sarkis, A. S., Reuter, V. E., and Cordon Cardo, C. Altered patterns of MDM2 and TP53 expression in human bladder cancer. J. Natl. Cancer Inst., 86: 1325-1330. 1994.